POLYMUN Scientifc Immunbiologische Forschung GmbH
About POLYMUN Scientifc Immunbiologische Forschung
Polymun was founded in 1992 by Prof. Hermann Katinger.Revenues are generated by contract development and manufacturing of biopharmaceuticals and liposomal formulations of drugs. Revenues are invested in the proprietary product pipeline and the further development of technology platforms. The R&D projects and technologies are open for co-development and licensing. Polymun operates in accordance with current GMP guidelines and holds an Austrian production license for pharmaceuticals (§63 Austrian Pharmaceutical Law) thus meeting the EU requirements for drug manufacturing.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of POLYMUN Scientifc Immunbiologische Forschung
Similar companies
News about POLYMUN Scientifc Immunbiologische Forschung
Here you will find POLYMUN Scientifc Immunbiologische Forschung GmbH
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous